Combination perindopril/indapamide for the treatment of hypertension: A review

Bibliography

• Mancia G, Laurent S, Agabiti-Rosei E, Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27:2121-58
   PubMed Web of Science ®Google Scholar
• Alfakih K, Hall AS. Perindopril. Expert Opin Pharmacother 2006;12:63-71
   Google Scholar
• Sassard J, Bataillard A, McIntyre H. An overview of the pharmacology and clinical efficacy of indapamide sustained release. Fundam Clin Pharmacol 2005;19:637-45
   PubMed Web of Science ®Google Scholar
• McClellan KJ, Markham A. Perindopril 2 mg/indapamide 0.625 mg. Fixed low-dose combination. Drugs 1999;58:297-304
   PubMedGoogle Scholar
• Mourad JJ, Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients. Curr Med Res Opin 2009;25:2271-80
   PubMed Web of Science ®Google Scholar
• Dickerson JE, Hingorani AD, Ashby MJ, Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999;353:2008-13
   PubMed Web of Science ®Google Scholar
• Macfadyen RJ, Lees KR, Reid JL. Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs 1990;39(Suppl 1):49-63
   PubMedGoogle Scholar
• Pratt-Ubanama M, Oparil S. Thiazide and loop diuretics. In: McInnes G, editor. Clinical pharmacology and therapeutics of hypertension. Amsterdam: Elsevier BV; 2008. pp. 87-118
   Google Scholar
• Schiavi P, Piraube C, Lachau-Durand S, Pharmacokinetic evaluation of a potential interaction between perindopril and indapamide at steady-state after once daily administration. Am J Hypertens 1994;7:56A
   Google Scholar
• Meyrier A, Dratwa M, Sennesael J, Lachaud-Pettiti V. Fixed low-dose perindopril-indapamide combination in hypertensive patients with chronic renal failure. Am J Hypertens 1998;11:1087-92
   PubMedGoogle Scholar
• Forette B. Fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination in very elderly hypertensives [letter]. J Hum Hypertens 1999;13:211-13
   PubMedGoogle Scholar
• Wing LM, Arnolda LF, Harvey PJ, Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor. Blood Press 1998;7:299-307
   PubMedGoogle Scholar
• Matheson AJ, Cheer SM, Goa KL. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension. Drugs 2001;61:1211-29
   PubMed Web of Science ®Google Scholar
• Gosse P. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection. Expert Rev Cardiovasc Ther 2006;4:319-33
   PubMedGoogle Scholar
• Mallion JM, Chamontin B, Asmar R, Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Am J Hypertens 2004;17:245-51
   PubMed Web of Science ®Google Scholar
• de Luca N, Mallion JM, O'Rourke MF, Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens 2004;17:660-7
   PubMed Web of Science ®Google Scholar
• Dahlof B, Gosse P, Gueret P, Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study. J Hypertens 2005;23:2063-70
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Magagna A, Kardasz I, Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009;22:506-12
   PubMed Web of Science ®Google Scholar
• Jin Y, Thijs L, Richart T, Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res 2011;34:489-95
   Google Scholar
• Mogensen CE, Viberti G, Halimi S, Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression: PREMIER. Hypertension 2003;41:1063-71
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41
   PubMedGoogle Scholar
• Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305-15
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Group. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. Eur Heart J 2003;24:475-84
   PubMedGoogle Scholar
• Arima H, Tzourio C, Anderson C, Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 2010;41:394-6
   PubMed Web of Science ®Google Scholar
• Perkovic V, Ninomiya T, Arima H, Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS study. J Am Soc Nephrol 2007;18:2766-72
   PubMed Web of Science ®Google Scholar
• Hayen A, Bell K, Glasziou P, Monitoring adherence to medication by measuring change in blood pressure. Hypertension 2010;56:612-16
   PubMedGoogle Scholar
• The ADVANCE Collaborative Group. Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high-risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation. J Hypertens Suppl 2001;19:S21-8
   Google Scholar
• Patel A, MacMahon S, Chalmers J, Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40
   PubMed Web of Science ®Google Scholar
• Chalmers J, Arima H. Importance of blood pressure lowering in type 2 diabetes: focus on ADVANCE. J Cardiovasc Pharmacol 2010;55:340-7
   PubMedGoogle Scholar
• Glasziou PP, Clarke P, Alexander J, Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. Med J Aust 2010;193:320-4
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98
   PubMed Web of Science ®Google Scholar
• Peters R, Beckett N, Forette F, Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7:683-9
   PubMed Web of Science ®Google Scholar
• Bulpitt CJ, Beckett NS, Peters R, Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Hum Hypertens 10 March 2011 [Epub ahead of print]
   Google Scholar
• Peters R, Beckett N, Burch L, The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET). Age Ageing 2010;39:609-16
   PubMedGoogle Scholar
• Kang S, Wu YF, An N, Ren M. A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension. Clin Ther 2004;26:257-70
   PubMed Web of Science ®Google Scholar
• www.lareb.nl. [Last accessed 10 March 2010]
   Google Scholar